Scilex Holding Company, a Sorrento Company, Announces That :

SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the...

Related Keywords

California , United States , San Diego , Palo Alto , Americans , Jaisim Shah , Dmitri Lissin , Department Of The Institute For Health Metrics , Drug Administration , Vickers Vantage Corp , Scilex Holding Company , Nasdaq , Vickers Venture Fund Vi Pte Ltd , Sorrento Therapeutics Inc , University Of Washington , Vickers Venture Fund Vi Plan Pte Ltd , Pivotal Trialc Le Ar Program , Company Or Scilex , Fast Track Designation , Accelerated Approval , Priority Review , New Drug Application , Holding Company , Sorrento Therapeutics , Chief Medical Officer , Fast Track , Chief Executive Officer , Health Metrics , Subjects With Moderate , Severe Acute Lower Back Pain , Text View , United States Federal Food , Cosmetic Act , Vickers Vantage , Vickers Venture Fund , Pte Ltd , Corticosteroid Lumbar Epidural Analgesia , Full Text View , Registration Statement , Combined Company , Securities Act , Private Securities Litigation Reform Act , Nasdaq Capital Market , Nasdaq Srne , Nc ,